Symbol
| TBX2
| contributors: mct/pgu - updated : 29-08-2016
|
HGNC name
| T-box 2
|
HGNC id
| 11597
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
| amplification
|  
|  
|
in primary breast and ovarian cancer | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | reproductive | uterus | |
PSCA and TBX2 might be candidate targets for cancer therapy in endometrial adenocarcinoma |
| | | |
| Tbx2 in the embryonic mouse heart at early stages of development throughout the myocardium of the heart tube both represses proliferation and impairs secondary heart field (SHF) progenitor cell deployment into the outflow tract (OFT), implicating the upregulation of Ndrg2 and downregulation of Ndrg4 expression | |
lungs of Tbx2-deficient mice are markedly hypoplastic and exhibit reduced branching morphogenesis |